Journal article
A pharmacist intervention for monitoring and treating hypertension using bidirectional texting: PharmText BP
Contemporary clinical trials, Vol.98, pp.106169-106169
11/2020
DOI: 10.1016/j.cct.2020.106169
PMCID: PMC7686143
PMID: 33038500
Abstract
New approaches are needed to better monitor blood pressure (BP) between physician visits, especially for patients in rural areas or for those who lack transportation. We have developed a custom-built bi-directional texting platform for home BP measurements that can then be managed by clinical pharmacists located remotely. The purpose of this study is to evaluate whether the BP texting approach combined with a pharmacist-based intervention improves BP management and to determine if the approach is cost effective.
This study is a randomized, prospective trial in four primary care offices that serve patients in rural areas. Subjects will receive standardized research BP measurements at baseline, 6 and 12 months. The primary outcome will be differences between the intervention and control group in mean systolic BP at 12 months. Secondary outcomes will include systolic BP at 6 months; diastolic BP at 6 and 12 months, number of medication changes and costs.
This study plans to enroll subjects through 2022, follow-up will be completed in 2023 and results will be available in 2024. This study will provide information on whether a combined approach using texting of home BP values and a pharmacist-based telehealth services can improve BP control.
Details
- Title: Subtitle
- A pharmacist intervention for monitoring and treating hypertension using bidirectional texting: PharmText BP
- Creators
- Linnea A Polgreen - Department of Pharmacy Practice and Science, College of Pharmacy, University of Iowa, USABarry L Carter - Department of Pharmacy Practice and Science, College of Pharmacy, University of Iowa, USAPhilip M Polgreen - Department of Internal Medicine, College of Medicine, University of Iowa, USAPeter M Snyder - Department of Internal Medicine, College of Medicine, University of Iowa, USADaniel K Sewell - Department of Biostatistics, College of Public Health, University of Iowa, USAEmine O Bayman - Department of Biostatistics, College of Public Health, University of Iowa, USAShelby L Francis - Department of Internal Medicine, College of Medicine, University of Iowa, USAJacob E Simmering - Department of Internal Medicine, College of Medicine, University of Iowa, USAChristopher Parker - Department of Pharmacy Practice and Science, College of Pharmacy, University of Iowa, USARachel Finkelstein - Department of Pharmacy Practice and Science, College of Pharmacy, University of Iowa, USA
- Resource Type
- Journal article
- Publication Details
- Contemporary clinical trials, Vol.98, pp.106169-106169
- DOI
- 10.1016/j.cct.2020.106169
- PMID
- 33038500
- PMCID
- PMC7686143
- NLM abbreviation
- Contemp Clin Trials
- ISSN
- 1551-7144
- eISSN
- 1559-2030
- Publisher
- Elsevier Inc
- Grant note
- DOI: 10.13039/100000050, name: National Heart, Lung, and Blood Institute, award: HL144880, UL1TR002537
- Language
- English
- Date published
- 11/2020
- Academic Unit
- Infectious Diseases; Health Management and Policy; Biostatistics; Pharmacy Practice and Science; Anesthesia; Injury Prevention Research Center; Molecular Physiology and Biophysics; Pulmonary, Critical Care, and Occupational Medicine; Epidemiology; Economics; Cardiovascular Medicine; Fraternal Order of Eagles Diabetes Research Center; Public Policy Center (Archive); Medicine Administration; Internal Medicine
- Record Identifier
- 9984214795202771
Metrics
30 Record Views